Robert L. Zerbe M.D., Director at Vericel Corp (VCEL), sold 300 shares at $38.00 ($11K) on 2023-11-15, disclosed to the SEC on 2023-11-17.
Scheduled sale ($11k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.00 | 200 | $8K | 66.6% |
| 2 | $38.06 | 100 | $4K | 33.4% |
| Total | $38.02 avg | 300 | $11K | 100% |
| Filing → |
| VCEL | SELL | 2024-11-13 | $281K | — | Filing → |
| VCEL | SELL | 2024-03-29 | $338K | — | Filing → |
| VCEL | SELL | 2024-02-22 | $36K | — | Filing → |